Episode summary
BI Weekend: Live Nation Suit, Micron Earnings, Kimmel Return | Bloomberg Intelligence
Bloomberg Intelligence
· · Hosts: Paul Sweeney, Scarlet Fu · Guests: Jennifer Rie, Jake Silverman, Sam Fazeli, Ann Hunter, Mark Gurman, John Butler, Geetha Ranganathan, Michael Halen
Summary
The episode centered on several company-specific catalysts that all had a common thread: regulators, AI, or consumer behavior are reshaping earnings and strategy. The host and co-host began with Live Nation, where Jennifer Rie said the FTC ticketing suit was not a surprise given prior enforcement actions and the March executive order on the Bots Act. She argued the FTC case could settle, while the DOJ antitrust case could still take years and may ultimately push Live Nation toward selling Ticketmaster.
Micron’s quarter was framed as a classic case of high expectations outrunning strong fundamentals. Jake Silverman said AI demand, especially for high-bandwidth memory, is tightening supply and supporting pricing, which could extend the memory upcycle well beyond a normal cycle. The show also covered Pfizer’s $4.9 billion Metsera deal, with Sam Fazeli saying obesity remains a huge market and that the science still needs phase-three proof.
Other segments focused on Tylenol scrutiny, Oura’s latest fundraise, T-Mobile’s CEO transition, Jimmy Kimmel’s return, and Starbucks’ restructuring. Across those stories, the analysts repeatedly emphasized that political pressure, platform shifts, and operational fixes can move stocks in the short run, but the financial impact varies widely by company.
Key takeaways
- Jennifer Rie said the FTC’s Live Nation case likely settles, but the DOJ case could still go to trial in March and drag on for years.
- Jake Silverman said Micron’s AI-driven memory upcycle may last at least 12 quarters, supported by demand for high-bandwidth memory and constrained supply.
- Sam Fazeli said Pfizer’s $4.9 billion Metsera deal is a bid to enter obesity medicine, but the asset still needs stronger phase-three data.
- Ann Hunter said the Tylenol-autism claim rests on correlation, not causation, and she does not expect a material sales hit to Kenvue.
- John Butler said T-Mobile’s next growth driver is broadband, especially if the new CEO moves aggressively into fiber.
- Githa Ranganathan said Jimmy Kimmel matters more culturally than financially because late-night TV has become a much smaller ad business for Disney.
Notable quotes
“the FTC lawsuit over the bots act probably ends in a settlement because the penalties are astronomical”
“we're going to continue to see an upcycle in memory, at least for the near term”
“as long as demand for AI continues to grow we'll see further pricing increases”
“correlation is not causation. Those are two separate things”
“They don't make a whole lot of money, Paul. Not anymore”
How the episode opens
Bloomberg Audio Studios, podcasts, radio news. This is Bloomberg Intelligence — With Scarlett Fu and Paul Sweeney. — How do you think the Fed is looking at tariffs, the uncertainty of tariffs? — Let's take a look at the sectors and how they perform.
A lot of investors getting whipsawed every day by news events, — Breaking market headlines — And corporate news from across the globe. — Could we see a market disruption, a market event? Are people just too exuberant out there? — You see some so-called lowquality stocks driving this short-term rally.
Bloomberg Intelligence — With Scarlet Fu and Paul Sweeney on Bloomberg Radio, YouTube, and Bloomberg Originals.
On today's Bloomberg Intelligence Show, we dig inside the big business stories impacting Wall Street and the global markets. Each and every week, we provide in-depth research and data on some of the 2,000 companies and 130 industries our analysts cover worldwide. Today, we'll look at why the Trump administration is warning about Tylenol use during pregnancy.
Plus, we'll look at what's in store for the telecommunications company T-Mobile after naming a new CEO. But first, we begin in the antirust space. We recently heard that the US Federal Trade Commission and seven states have sued Live Nation Entertainment and his ticket master subsidiary.
It's for failing to prevent the use of automated ticketing bots and large-scale resale operations. For more, co-host Scarlett Phil and I were joined by Jennifer Ree, Bloomberg Intelligence senior litigation analyst. We first asked for Jen's first impressions on the latest news.
Well, I think first of all, not too much of a surprise because they did recently sue a much smaller entity um over the same law, which is called the Better Ticketing Online Sales Act or the Bots Act.
From the episode’s captions: roughly the first two minutes, lightly cleaned. Keep watching on YouTube →
Topics
- ftc lawsuit
- semiconductor earnings
- pharma m&a
- late night return
- retail and consumer stocks
Companies and tickers mentioned
- LYV
- MU
- PFE
- JNJ
- TMUS
- SBUX
- Live Nation Entertainment
- Micron Technology
- Pfizer
- Metsera
- Tylenol
- Johnson & Johnson
- Oura
- T-Mobile US
- Starbucks
- Bloomberg L.P.
Watch the episode
Summary, takeaways and quote selection by Octagon. Quotes are short excerpts; the full conversation is in the episode.
More from Bloomberg Intelligence
-
Instant Reaction: Nvidia CEO Jensen Huang Ousted by Nvidia Board | Bloomberg Intelligence -
Nvidia’s Huang Ousted by Board in Move That Roils AI Economy | Bloomberg Intelligence -
CoreWeave Shares Soar After AI Computing Firm Eases Debt Fears | Bloomberg Intelligence -
Anthropic Targets $1.4 Trillion Valuation in Blockbuster IPO | Bloomberg Intelligence -
Nvidia Probe Into CEO Affair Raises Thorny Questions for AI | Bloomberg Intelligence -
Election 'Blue Wave' & Your Wallet; Navigating AI-Driven Market Volatility | Bloomberg Intelligence
Bloomberg Intelligence, this episode and its artwork belong to Bloomberg. Octagon is not affiliated with the show; this page is an independent summary.
